Data is not available at this time.
FMC Corporation operates as a global agricultural sciences company, specializing in crop protection solutions through innovative insecticides, herbicides, and fungicides. The company serves large-scale agricultural producers and smaller farming operations, leveraging its R&D capabilities to develop sustainable and high-efficacy products. FMC’s revenue model is driven by chemical sales, licensing agreements, and tailored solutions for pest and disease management, positioning it as a key player in the agrochemical sector. The company competes with multinational firms like Bayer and Syngenta, differentiating itself through proprietary chemistries and a focus on emerging markets. Its market position is reinforced by a robust product pipeline and strategic partnerships with distributors and farmers worldwide. FMC’s ability to address evolving regulatory and environmental challenges further strengthens its industry standing.
FMC reported revenue of $4.25 billion for FY 2024, with net income of $339.9 million, reflecting a net margin of approximately 8%. Diluted EPS stood at $2.72, while operating cash flow reached $671.1 million, indicating solid cash generation. The absence of reported capital expenditures suggests disciplined spending or potential data limitations, warranting further scrutiny.
The company’s earnings power is supported by its agrochemical portfolio, though net income margins indicate moderate profitability. Operating cash flow coverage of net income (1.97x) suggests efficient cash conversion. However, high total debt of $3.5 billion relative to cash reserves ($357.3 million) raises questions about leverage management and capital allocation efficiency.
FMC’s balance sheet shows $357.3 million in cash against $3.5 billion in total debt, highlighting a leveraged position. The debt-to-equity ratio appears elevated, potentially constraining financial flexibility. Shareholders’ equity and liquidity metrics would provide deeper insight, but absent data limits a full assessment of solvency risks.
FMC’s dividend payout of $2.33 per share suggests a commitment to returning capital, though the sustainability depends on future cash flows and debt servicing. Growth prospects hinge on product innovation and expansion in emerging markets, but macroeconomic and regulatory headwinds in agriculture could temper near-term performance.
With a market cap inferred from shares outstanding (124.9 million) and assuming a typical trading range, FMC’s valuation likely reflects moderate growth expectations. Investors may weigh its agrochemical niche against sector volatility and input cost pressures, pricing in a risk premium for its leveraged balance sheet.
FMC’s strengths lie in its R&D-driven product portfolio and global distribution network. However, debt levels and competitive pressures pose challenges. The outlook depends on executing innovation cycles and managing leverage, with sustainability initiatives potentially unlocking long-term value in a shifting regulatory landscape.
FMC Corporation 10-K (CIK: 0000037785), FY 2024 preliminary data
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |